Brian Dorsey - 06 Dec 2022 Form 3 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)

Role
Chief Operating Officer
Signature
/s/ Kathleen Scott, Attorney-in-Fact
Issuer symbol
SPRY
Transactions as of
06 Dec 2022
Net transactions value
$0
Form type
3
Filing time
09 Dec 2022, 16:06:41 UTC
Next filing
05 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SPRY Stock option (right to buy) 06 Dec 2022 Common Stock 141,828 $0.6300 Direct
holding SPRY Stock option (right to buy) 06 Dec 2022 Common Stock 85,687 $0.7900 Direct
holding SPRY Stock option (right to buy) 06 Dec 2022 Common Stock 127,645 $0.8400 Direct
holding SPRY Stock option (right to buy) 06 Dec 2022 Common Stock 82,733 $0.8400 Direct
holding SPRY Stock option (right to buy) 06 Dec 2022 Common Stock 82,733 $1.44 Direct
holding SPRY Stock option (right to buy) 06 Dec 2022 Common Stock 82,733 $1.44 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.